🏥 Modern PCI, 🫀 MI Managed, 💉 Aspirin Dropped Early, 📉 Bleeds Reduced

💡 TARGET-FIRST trial (NEJM, Aug 2025) shows that in low-risk AMI patients post-PCI with complete revascularization, stopping aspirin after 1 month and continuing P2Y12 monotherapy is noninferior to dual antiplatelet therapy—with 54% fewer bleeding events 🩸🛑💊   ⚖️ A modern, patient-tailored antiplatelet strategy—backed by potent P2Y12 inhibitors and smart selection—might just be the new norm in contemporary cardiology 🫀   📘 New England Journal of Medicine 🔗 https://doi.org/10.1056/NEJMoa2508808   #Cardiology #DAPT #PrecisionMedicine #NEJM #TARGETFIRST